Form 4: Atea Pharmaceuticals Director Bruno Lucidi Acquires Stock Options and Restricted Stock Units

Director Bruno Lucidi reports acquisition of stock options and restricted stock units in Atea Pharmaceuticals, Inc.

Summary

• On June 21, 2024, Bruno Lucidi, a director of Atea Pharmaceuticals, Inc., acquired 41,200 stock options with an exercise price of $3.44, expiring on June 20, 2034.
• These options vest in twelve substantially equal monthly installments following June 21, 2024, becoming fully vested on the first anniversary of the grant date, contingent upon continued service.
• Lucidi also acquired 29,600 restricted stock units (RSUs) that convert into common stock on a one-for-one basis.
• The RSUs vest on the earlier of the next annual meeting of the Issuer's stockholders or the first anniversary of the grant date, also subject to continued service.
• Following these transactions, Lucidi directly owns 41,200 stock options and 29,600 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of stock options and RSUs can be seen as a positive sign, but it's not a major event.

Positives

• The acquisition of stock options and restricted stock units by a director signals confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Stock option and RSU grants are standard compensation practices for directors and executives in the pharmaceutical industry.
• Vesting schedules, such as monthly vesting over one year for options and vesting upon the next annual meeting for RSUs, are typical.
• Companies like Gilead Sciences and Vertex Pharmaceuticals also utilize stock options and RSUs as part of their executive compensation packages.

Stakeholder Impact

• The acquisition of stock options and RSUs by a director can positively influence shareholder sentiment, reflecting confidence in the company's future.

Key Dates